期刊论文详细信息
BMC Nephrology
Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology
Draga Toncheva7  Angel Galabov4  Valentin Djonov5  Ruslan Hlushchuk5  Ivanka Dimova7  Momir Polenakovic2  Vladislav Stefanovic6  Jovana Cukuranovic6  Rade Cukuranovic6  Georgi Stamenov1  Valeri Simeonov8  Plamen Dimitrov3  Olga Antonova7  Desislava Nesheva7  Savina Hadjidekova7  Blaga Rukova7  Rada Staneva7 
[1] Nadezhda Center for reproductive help, 3 Blaga Vest str, 1330 Sofia, Bulgaria;Macedonian Academy of Sciences and Arts, Bul. Krste Misirkov, 2, P.O. Box 428, 1000 Skopje, Republic of Macedonia;National Center of Public Health and Analyses, 15 Acad. Ivan Evst. Geshov blvd, 1431 Sofia, Bulgaria;Institute of Microbilogy, Bulgarian Academy of Sciences, 26 Georgi Bonchev str, 1113 Sofia, Bulgaria;Institute of Anatomy, Bern University, Baltzerstrasse 2, CH 3012 Bern, Switzerland;Faculty of Medicine, Institute of Nephrology, University of Nis, Univerzitetski trg 2, 18000 Nis, Serbia;Department of Medical Genetics, Medical University of Sofia, 1421 2Zdrave str, Sofia, Bulgaria;Vratza District Hospital, 66 “Vtori iuni” blvd, Vratza, Bulgaria
关键词: Balkan endemic nephropathy;    Whole genome array analysis;    Epigenetics;   
Others  :  1082814
DOI  :  10.1186/1471-2369-14-225
 received in 2013-04-15, accepted in 2013-10-11,  发布年份 2013
PDF
【 摘 要 】

Background

Balkan endemic nephropathy (BEN) represents a chronic progressive interstitial nephritis in striking correlation with uroepithelial tumours of the upper urinary tract. The disease has endemic distribution in the Danube river regions in several Balkan countries.

DNA methylation is a primary epigenetic modification that is involved in major processes such as cancer, genomic imprinting, gene silencing, etc. The significance of CpG island methylation status in normal development, cell differentiation and gene expression is widely recognized, although still stays poorly understood.

Methods

We performed whole genome DNA methylation array analysis on DNA pool samples from peripheral blood from 159 affected individuals and 170 healthy individuals. This technique allowed us to determine the methylation status of 27 627 CpG islands throughout the whole genome in healthy controls and BEN patients. Thus we obtained the methylation profile of BEN patients from Bulgarian and Serbian endemic regions.

Results

Using specifically developed software we compared the methylation profiles of BEN patients and corresponding controls and revealed the differently methylated regions. We then compared the DMRs between all patient-control pairs to determine common changes in the epigenetic profiles.

SEC61G, IL17RA, HDAC11 proved to be differently methylated throughout all patient-control pairs. The CpG islands of all 3 genes were hypomethylated compared to controls. This suggests that dysregulation of these genes involved in immunological response could be a common mechanism in BEN pathogenesis in both endemic regions and in both genders.

Conclusion

Our data propose a new hypothesis that immunologic dysregulation has a place in BEN etiopathogenesis.

【 授权许可】

   
2013 Staneva et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20141224183027964.pdf 302KB PDF download
Figure 2. 64KB Image download
Figure 1. 25KB Image download
【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】
  • [1]DeBroe ME: Clinical Nephrotoxins. London, New York: Renal Injury from Drugs and Chemicals 3rd ed, Springer; 2008:844-845.
  • [2]Radovanovic Z: Epidemiological characteristics of Balkan endemic nephropathy in eastern regions of Yugoslavia. IARC Sci Publ 1991, 115:11-20.
  • [3]Gubev ED: I: study on Balkan endemic nephropathy. Internal medicine 1972, 3:118-121.
  • [4]Chernozemsky IN: Balkan endemic nephropathy and the associated tumours of the urinary system: a summary of epidemiological features in Bulgaria. Iarc Sci Publ 1991, 115:3-4.
  • [5]Nikolov IG, Petkova-Bocharova D, Castegnaro M, Pfohl-Leskowicz A, Gill C, Day N, Chernozemsky IN: Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy. Journal of environmental pathology, toxicology and oncology: official organ of the International Society for Environmental Toxicology and Cancer 1996, 15(2–4):201-207.
  • [6]Long DT, Icopini G, Ganev V, Petropoulos E, Havezov I, Voice T, Chou K, Spassov A, Stein A: Geochemistry of Bulgarian soils in villages affected and not affected by Balkan endemic nephropathy: a pilot study. International journal of occupational medicine and environmental health 2001, 14(2):193-196.
  • [7]Schmeiser HH, Kucab JE, Arlt VM, Phillips DH, Hollstein M, Gluhovschi G, Gluhovschi C, Modilca M, Daminescu L, Petrica L, et al.: Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania. Environmental and molecular mutagenesis 2012, 53(8):636-641.
  • [8]Krogh P: Role of ochratoxin in disease causation. Food Chem Toxicol 1992, 30(3):213-224.
  • [9]Riquelme C, Escors D, Ortego J, Sanchez CM, Uzelac-Keserovic B, Apostolov K, Enjuanes L: Nature of the virus associated with endemic Balkan nephropathy. Emerging infectious diseases 2002, 8(8):869-870.
  • [10]Uzelac-Keserovic B, Vasic D, Ikonomovski J, Bojanic N, Apostolov K: Isolation of a coronavirus from urinary tract tumours of endemic Balkan nephropathy patients. Nephron 2000, 86(1):93-94.
  • [11]Toncheva D, Dimitrov T: Genetic predisposition to Balkan endemic nephropathy. Nephron 1996, 72(4):564-569.
  • [12]Toncheva D, Dimitrov T, Stojanova S: Etiology of Balkan endemic nephropathy: a multifactorial disease? European journal of epidemiology 1998, 14(4):389-394.
  • [13]Nikolov IG, Chernozemsky IN, Idle JR: Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor. Iarc Sci Publ 1991, 115:289-296.
  • [14]Pavlovic NM, Varghese Z, Persaud JW, Stefanovic V, Strahinjic S, Savic V, Moorehead JF: Partial lecithin:cholesterol acyltransferase (LCAT) deficiency in Balkan endemic nephropathy. Kidney international Supplement 1991, 34:S102-104.
  • [15]Toncheva D, Dimitrov T, Tzoneva M: Cytogenetic studies in Balkan endemic nephropathy. Nephron 1988, 48(1):18-21.
  • [16]Toncheva DI, Gergov TD, Tzoneva MT, Bouchakliev ZP: Spontaneous and induced chromosome-aberrations in Balkan endemic nephropathy. Kidney international 1991, 40:S97-S101.
  • [17]Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP: Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS genetics 2007, 3(10):2023-2036.
  • [18]Ekstrom TJ, Stenvinkel P: The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications? Journal of nephrology 2009, 22(4):442-449.
  • [19]Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekstrom TJ, Harris TB, et al.: Intra-individual change over time in DNA methylation with familial clustering. JAMA: the journal of the American Medical Association 2008, 299(24):2877-2883.
  • [20]Vavouri T, Lehner B: Human genes with CpG island promoters have a distinct transcription-associated chromatin organization. Genome biology 2012, 13(11):R110. BioMed Central Full Text
  • [21]Kakumani R, Ahmad O, Devabhaktuni V: Identification of CpG islands in DNA sequences using statistically optimal null filters. EURASIP journal on bioinformatics & systems biology 2012, 2012(1):12. BioMed Central Full Text
  • [22]Jones PA: Cancer. Death and methylation. Nature 2001, 409(6817):143-144.
  • [23]Stefanovic V, Jelakovic B, Cukuranovic R, Bukvic D, Nikolic J, Lukic L, Gluhovschi G, Toncheva D, Polenakovic M, Cosyns JP: Diagnostic criteria for Balkan endemic nephropathy: proposal by an international panel. Renal failure 2007, 29(7):867-880.
  • [24]Atanasova S: The role of some polymorphisms of detoxicating enzyme for predisposition to Balkan endemic nephropathy. Medical University of Sofia: PhD thesis; 2003.
  • [25]Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, et al.: An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome research 2008, 18(9):1518-1529.
  • [26]Marsit CJ, Houseman EA, Christensen BC, Gagne L, Wrensch MR, Nelson HH, Wiemels J, Zheng S, Wiencke JK, Andrew AS, et al.: Identification of methylated genes associated with aggressive bladder cancer. PloS one 2010, 5(8):e12334.
  • [27]Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA: Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC medical genomics 2010, 3:33. BioMed Central Full Text
  • [28]Ingrosso D, Perna AF: Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochimica et biophysica acta 2009, 1790(9):892-899.
  • [29]Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S: Epigenetic clues to rheumatoid arthritis. Journal of autoimmunity 2008, 30(1–2):12-20.
  • [30]Hiltunen MO, Yla-Herttuala S: DNA methylation, smooth muscle cells, and atherogenesis. Arteriosclerosis, thrombosis, and vascular biology 2003, 23(10):1750-1753.
  • [31]Gao L, Cueto MA, Asselbergs F, Atadja P: Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. The Journal of biological chemistry 2002, 277(28):25748-25755.
  • [32]Peter L: Towards an Understanding of the Biological Function of Histone Acetylation. FEBS Letters 1988, 227(2):91-95.
  • [33]McGovern DP, Rotter JI, Mei L, Haritunians T, Landers C, Derkowski C, Dutridge D, Dubinsky M, Ippoliti A, Vasiliauskas E, et al.: Genetic epistasis of IL23/IL17 pathway genes in Crohn’s disease. Inflammatory bowel diseases 2009, 15(6):883-889.
  • [34]Raychaudhuri SP, Raychaudhuri SK, Genovese MC: IL-17 receptor and its functional significance in psoriatic arthritis. Molecular and cellular biochemistry 2012, 359(1–2):419-429.
  • [35]Greenfield JJA, High S: The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. J Cell Sci 1999, 112(10):1477-1486.
  • [36]Kolker E, Higdon R, Haynes W, Welch D, Broomall W, Lancet D, Stanberry L, Kolker N: MOPED: model organism protein expression database. Nucleic acids research 2012, 40(Database issue):1093-1099.
  文献评价指标  
  下载次数:0次 浏览次数:0次